146 related articles for article (PubMed ID: 27335039)
1. Involvement of the Septo-Hippocampal Cholinergic Pathway in Association with Septal Acetylcholinesterase Upregulation in a Mouse Model of Tauopathy.
Hara Y; Motoi Y; Hikishima K; Mizuma H; Onoe H; Matsumoto SE; Elahi M; Okano H; Aoki S; Hattori N
Curr Alzheimer Res; 2017; 14(1):94-103. PubMed ID: 27335039
[TBL] [Abstract][Full Text] [Related]
2. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.
García-Gómez BE; Fernández-Gómez FJ; Muñoz-Delgado E; Buée L; Blum D; Vidal CJ
J Mol Neurosci; 2016 Apr; 58(4):411-5. PubMed ID: 26697857
[TBL] [Abstract][Full Text] [Related]
3. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
[TBL] [Abstract][Full Text] [Related]
4. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice.
Kambe T; Motoi Y; Inoue R; Kojima N; Tada N; Kimura T; Sahara N; Yamashita S; Mizoroki T; Takashima A; Shimada K; Ishiguro K; Mizuma H; Onoe H; Mizuno Y; Hattori N
Neurobiol Dis; 2011 Jun; 42(3):404-14. PubMed ID: 21324362
[TBL] [Abstract][Full Text] [Related]
5. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model.
Zadrozny M; Drapich P; Gasiorowska-Bien A; Niewiadomski W; Harrington CR; Wischik CM; Riedel G; Niewiadomska G
Cells; 2024 Apr; 13(7):. PubMed ID: 38607082
[TBL] [Abstract][Full Text] [Related]
7. Reorganization of the septohippocampal cholinergic fiber system in experimental epilepsy.
Soares JI; Valente MC; Andrade PA; Maia GH; Lukoyanov NV
J Comp Neurol; 2017 Aug; 525(12):2690-2705. PubMed ID: 28472854
[TBL] [Abstract][Full Text] [Related]
8. Selective degeneration of septal and hippocampal GABAergic neurons in a mouse model of amyloidosis and tauopathy.
Loreth D; Ozmen L; Revel FG; Knoflach F; Wetzel P; Frotscher M; Metzger F; Kretz O
Neurobiol Dis; 2012 Jul; 47(1):1-12. PubMed ID: 22426397
[TBL] [Abstract][Full Text] [Related]
9. Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model.
Houben S; Leroy K; Ando K; Yilmaz Z; Widomski C; Buée L; Brion JP
Neurobiol Dis; 2019 Jul; 127():131-141. PubMed ID: 30818066
[TBL] [Abstract][Full Text] [Related]
10. Developmental cholinotoxicity of lead: loss of septal cholinergic neurons and long-term changes in cholinergic innervation of the hippocampus in perinatally lead-exposed rats.
Bourjeily N; Suszkiw JB
Brain Res; 1997 Oct; 771(2):319-28. PubMed ID: 9401752
[TBL] [Abstract][Full Text] [Related]
11. Electroacupuncture in rats normalizes the diabetes-induced alterations in the septo-hippocampal cholinergic system.
Protto V; Soligo M; De Stefano ME; Farioli-Vecchioli S; Marlier LNJL; Nisticò R; Manni L
Hippocampus; 2019 Oct; 29(10):891-904. PubMed ID: 30870587
[TBL] [Abstract][Full Text] [Related]
12. IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins.
Beck RD; King MA; Ha GK; Cushman JD; Huang Z; Petitto JM
J Neuroimmunol; 2005 Mar; 160(1-2):146-53. PubMed ID: 15710467
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
Köhler C; Bista P; Götz J; Schröder H
Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
[TBL] [Abstract][Full Text] [Related]
14. Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease.
Belarbi K; Schindowski K; Burnouf S; Caillierez R; Grosjean ME; Demeyer D; Hamdane M; Sergeant N; Blum D; Buée L
Curr Alzheimer Res; 2009 Apr; 6(2):152-7. PubMed ID: 19355850
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in the morphology of the septo-hippocampal cholinergic and GABAergic system in mice. I. Cholinergic and GABAergic markers.
Schwegler H; Boldyreva M; Pyrlik-Göhlmann M; Linke R; Wu J; Zilles K
Hippocampus; 1996; 6(2):136-48. PubMed ID: 8797015
[TBL] [Abstract][Full Text] [Related]
16. Alterations in septohippocampal cholinergic neurons resulting from interleukin-2 gene knockout.
Beck RD; King MA; Huang Z; Petitto JM
Brain Res; 2002 Nov; 955(1-2):16-23. PubMed ID: 12419517
[TBL] [Abstract][Full Text] [Related]
17. Impaired hippocampal and thalamic acetylcholine release in P301L tau-transgenic mice.
Stein C; Koch K; Hopfeld J; Lobentanzer S; Lau H; Klein J
Brain Res Bull; 2019 Oct; 152():134-142. PubMed ID: 31323279
[TBL] [Abstract][Full Text] [Related]
18. Selective septohippocampal - but not forebrain amygdalar - cholinergic dysfunction in diencephalic amnesia.
Savage LM; Roland J; Klintsova A
Brain Res; 2007 Mar; 1139():210-9. PubMed ID: 17289001
[TBL] [Abstract][Full Text] [Related]
19. Loss of cholinergic phenotype in septohippocampal projection neurons: relation to brain versus peripheral IL-2 deficiency.
Meola DM; Huang Z; King M; Petitto JM
Neurosci Lett; 2013 Feb; 539():60-4. PubMed ID: 23416322
[TBL] [Abstract][Full Text] [Related]
20. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
